IMVT Immunovant, Inc.

NASDAQ
$44.37

Immunovant, Inc. (IMVT) SEC Filings

Everything IMVT has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

1 filings
Date Form Filing
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.